Elanco Animal Health Among Today's Trending Stocks

10:38am, Wednesday, 11'th Aug 2021
Q.ai runs daily factor models to get the most up-to-date reading on stocks and ETFs. Today, our deep-learning algorithms have identified Elanco Animal Health among others.
The stock price of Elanco, a pharmaceuticals company focused on medicines for pets and livestock, has seen a large 19% fall over the last five trading days, and much of this fall has come in yesterday
NORWALK, Conn., Aug. 11, 2021 /PRNewswire/ -- TriRx Pharmaceutical Services, LLC, a leading international CDMO, hosted Kansas Lt.
NEW YORK--(BUSINESS WIRE)--Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Elanco Animal Health Incorporated (“Elanco” o
Los Angeles, California--(Newsfile Corp. - August 10, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of El
SAN FRANCISCO, Aug. 10, 2021 /PRNewswire/ -- Hagens Berman urges Elanco Animal Health, Inc. (NYSE: ELAN) investors with significant losses to submit your losses now. The firm is investigating possib
SAN DIEGO, Aug. 10, 2021 /PRNewswire/ -- Shareholder rights law firm Johnson Fistel, LLP is investigating potential violations of the federal securities laws by Elanco Animal Health Incorporated ("Ela
NEW YORK, Aug. 9, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Elanco Animal Health Incorporated ("Elanco" or the "Company") (NYSE: ELAN). Such investors a
Atlanta, Georgia--(Newsfile Corp. - August 9, 2021) - Holzer & Holzer, LLC is investigating whether Elanco Animal Health Incorporated ("Elanco" or the "Company") (NYSE: ELAN) complied with federal sec
LOS ANGELES--(BUSINESS WIRE)---- $ELAN #ELAN--INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Elanco Animal Health Incorporated.
Elanco Animal Health Inc. (ELAN) CEO Jeff Simmons on Q2 2021 Results - Earnings Call Transcript
A downward guidance revision for 2021 earnings is overshadowing impressive sales growth.
Elanco Animal Health Inc (NYSE: ELAN) has reported Q2 EPS of $0.28 higher than $0.09 reported a year ago, surpassing analysts' estimate of $0.26 and the company guidance of $0.22 - $0.27. Sales of
Boston, Massachusetts--(Newsfile Corp. - August 9, 2021) - Block & Leviton is investigating Elanco Animal Health Incorporated (NYSE: ELAN) for potential securities law violations. Investors who have l
Elanco Animal Health Incorporated (ELAN) delivered earnings and revenue surprises of 7.69% and 3.10%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for th
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE